The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 13, 2019

Filed:

Aug. 22, 2017
Applicant:

Taiho Pharmaceutical Co., Ltd., Tokyo, JP;

Inventors:

Masakazu Fukushima, Tokyo, JP;

Noriyuki Yamamoto, Tokyo, JP;

Norihiko Suzuki, Tokyo, JP;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/506 (2005.12); A61K 31/505 (2005.12); C07D 403/06 (2005.12); C07D 403/00 (2005.12); A61K 33/24 (2018.12); A61K 31/7072 (2005.12); A61K 9/48 (2005.12); A61K 9/20 (2005.12); A61K 9/16 (2005.12); A61K 9/02 (2005.12); A61K 9/00 (2005.12); A61K 45/06 (2005.12); A61K 31/4745 (2005.12); A61K 31/513 (2005.12);
U.S. Cl.
CPC ...
C07D 403/06 (2012.12); A61K 9/0019 (2012.12); A61K 9/0031 (2012.12); A61K 9/02 (2012.12); A61K 9/1652 (2012.12); A61K 9/2018 (2012.12); A61K 9/4858 (2012.12); A61K 31/4745 (2012.12); A61K 31/513 (2012.12); A61K 31/7072 (2012.12); A61K 33/24 (2012.12); A61K 45/06 (2012.12); Y10S 514/867 (2012.12);
Abstract

The present invention provides an agent for alleviating side effects caused by use of an anti-tumor agent, which contains 5-chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1H,3H-pyrimidi nedione (1) represented by formula (1): or a pharmaceutically acceptable salt thereof. The 5-chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1H,3H)-pyrimidinedione or a pharmaceutically acceptable salt thereof exhibit an inflammatory-suppressing action in the digestive tract and advantageously alleviate diarrhea and loss of body weight concomitant with administration of a chemical for treating cancer without suppressing the anti-tumor effect. Thus, the compounds of the present invention are of great value as agents for alleviating side effects caused by use of an anti-tumor agent, which enable not only the chemotherapy to be continuedly carried out, but also the body exhaustion to be effectively prevented.


Find Patent Forward Citations

Loading…